Form 4: West Pharmaceutical Services SVP, Chief Technology Officer, Silji Abraham, Reports Stock Option Exercise and Sale
SEC Form 4 Filing
Silji Abraham, SVP and Chief Technology Officer of West Pharmaceutical Services, exercised stock options and sold shares on February 23, 2024.
Summary
- On February 23, 2024, Silji Abraham, SVP, Chief Technology Officer of West Pharmaceutical Services, exercised stock options to acquire 7,012 shares of common stock at a price of $173.22 per share.
- Simultaneously, Mr. Abraham sold 7,012 shares of common stock at a price of $365 per share.
- Following these transactions, Mr. Abraham directly owns 4,660.258 shares of West Pharmaceutical Services common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| 02/18/2021 | Date stock options began vesting in four equal annual installments. |
| 02/23/2024 | Date of stock option exercise and sale of shares. |
| 02/26/2024 | Date of Form 4 signature. |
| 02/18/2030 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.